(Q40601251)

21 September 2017

Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells (English)

1 reference

21 September 2017

0 references

5

Samart Pakakasama

1 reference

21 September 2017

1

Suradej Hongeng

1 reference

21 September 2017

Sawang Petvises

2

1 reference

21 September 2017

Surapon Worapongpaiboon

series ordinal

3

1 reference

21 September 2017

Busaba Rerkamnuaychoke

series ordinal

4

1 reference

21 September 2017

Saengsuree Jootar

series ordinal

6

1 reference

21 September 2017

1 February 2003

1 reference

International Journal of Hematology

21 September 2017

1 reference

21 September 2017

77

1 reference

21 September 2017

2

1 reference

21 September 2017

175-179

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02983217

21 September 2017

0 references

cites work

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

1 reference

12 December 2020

Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.

1 reference

12 December 2020

Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells

1 reference

12 December 2020

Expansion of CD3+CD56+ cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy

1 reference

12 December 2020

Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice

1 reference

12 December 2020

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Allogeneic T-cell clones able to selectively destroy Philadelphia chromosome-bearing (Ph1+) human leukemia lines can also recognize Ph1- cells from the same patient.

1 reference

12 December 2020

A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent grade III/IV astrocytoma.

1 reference

12 December 2020

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

1 reference

12 December 2020

Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia

1 reference

12 December 2020

Cancer statistics, 1997.

1 reference

12 December 2020

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

1 reference

12 December 2020

Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer

1 reference

12 December 2020

Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression

1 reference

12 December 2020

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production

1 reference

12 December 2020

A subset of natural killer cells in peripheral blood displays a mature T cell phenotype

1 reference

12 December 2020

Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02983217

1 reference

21 September 2017

1 reference